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Regulation of glomerular cell number by apoptosis. While com- in the molecular mechanisms responsible for excessive
monly viewed as leading to glomerular scarring and end-stage glomerular cell proliferation, as this is commonly viewed
renal failure, glomerular cell proliferation may be a beneficial as an undesirable event that disturbs glomerular func-response that promotes the injured glomerulus to return to
tion, threatens progression to glomerular scarring andits proper function. This brief review looks at the potentially
end-stage renal failure, and therefore may warrant block-counterbalancing influences that cause glomerular cells to sur-
vive, undergo mitosis, differentiate or die. ade as a new approach to treatment [7].
However, a heretical view is that far from being unde-
sirable, glomerular cell proliferation is a beneficial re-
“. . . in this world nothing can be said to be certain, sponse that promotes healing and restitution of the in-
except death and taxes.” jured glomerulus. Perhaps the most dramatic evidence
Benjamin Franklin, 1789 in support of this concept comes from the well-described
Thy 1.1 model of mesangial proliferative nephritis in the
It is now widely recognized that physiological cell rat [9, 10]. The administration of cross-linking antibody
death by apoptosis is a normal event in tissue homeostasis to Thy 1.1 borne by mesangial cells leads to rapid, com-
[1, 2]. Indeed, apoptosis frequently appears to be a “tax” plement-mediated death of virtually all of the mesangial
on the growth of cell populations by mitosis [3, 4]. There- cells present in glomerular tufts. Remarkably, however,
fore, the U.S. statesman and author, Benjamin Franklin, over the ensuing weeks, normal glomerular structure and
would not have been surprised to find an article on the function are restored by processes that at times exhibit
counterbalancing roles of cell death in a symposium dedi- remarkable similarity to events that are commonly re-
cated to increase in cell number. This brief contribution, garded as “disease” in human glomeruli. Thus, within a
which concentrates on the mesangial cell, offers a per- few days, there is a profound “rebound” proliferation
sonal view on the role of apoptosis in the tissue kinetics of mesangial cells, so that by 10 to 14 days, the mesangial
of the diseased glomerulus. It is not intended to provide cell complement is double the normal number accompa-
a review of the molecular mechanisms that mediate apo- nied by an assumption of a myofibroblast phenotype
ptosis because these have been described in detail else- [11] and deposition of apparently excessive ECM [12].
where [5, 6], but some speculations on the regulation of However, far from inevitably leading to glomerular scar-
glomerular cell apoptosis are offered. ring, provided further insult is not added to initial Thy
1.1-mediated mesangial injury, beyond 14 days there is
progressive restitution of normal glomerular structureRESIDENT CELL NUMBER IN
via remodeling processes that include the return of theGLOMERULAR DISEASE
mesangial cell number to normal. Indeed, recent data
Nephrologists are more than familiar with the stereo- emphasize that much like the myofibroblasts that migrate
typed morphology of early glomerular disease, in which into tissue deficits in wounded skin [13–15], myofi-
infiltration by leukocytes and changes in the nature and broblast-like glomerular mesangial cells have the capac-
amount of extracellular matrix (ECM) are accompanied ity to move into and repair “gaps” left in the tissue
by an increase in the resident glomerular cell number by unscheduled cell death. A broadly similar course of
with evidence of true proliferation of glomerular cells events can be observed in human glomerular disease,
[7, 8]. Quite correctly, there has been intense interest with resolution occurring spontaneously in postinfec-
tious glomerulonephritis and some cases of IgA ne-
phropathy or after treatment in disorders such as lupusKey words: tissue homeostasis, cell death, mitosis, mesangial cells, glo-
merular cell apoptosis. nephritis.
Indeed, the heresy of beneficial glomerular cell prolif- 1999 by the International Society of Nephrology
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eration finds some support in the stereotyped morphol- mental differences, we were intrigued to find that glo-
merular cell apoptosis and mitosis peaked at the sameogy of late, end-stage glomerular disease. In addition to
shrinkage and apparent replacement of the glomerular early time point [3]. However, unlike mitosis, which re-
turned to baseline by 14 days, apoptosis remained tenfoldtuft by ECM, there is also a striking loss of glomerular
cells. Nevertheless, in what might be interpreted as the above baseline so long as the glomerular cell number was
greater than normal. By making some well-substantiatedlast stand of a defense force, there is evidence of in-
creased glomerular cell proliferation despite profound estimates of the duration that an individual apoptotic or
mitotic event was histologically detectable [31], we werehypocellularity [16].
able to use an “area under the curve” analysis to confirm
that the observed incidence of glomerular cell apoptosis
APOPTOSIS: FRIEND AND FOE
at various time points was sufficient to account for the
Of course, it is in the nature of debates between the observed rate of change in mesangial cell number. An
heretic and the orthodox that a balanced and correct interesting point was that apoptosis served as a “tax” on
view is rarely achieved. Indeed, recent data emphasize mitosis, limiting early increases in mesangial cell number
that the outcome of glomerular disease is most unlikely caused by cell proliferation.
to be determined solely by the regulation of resident cell However, this evidence for a beneficial role of apopto-
division [8]. Instead, it appears that a crucial factor is the sis was soon supplemented by data pointing toward unde-
balance between cell birth by mitosis, the main subject of sirable consequences of glomerular cell apoptosis. Sugi-
this symposium, and cell death by apoptosis. yama et al provided human and animal model data
Apoptosis is a physiological and “programmed” form supporting a role for unscheduled apoptosis in deleteri-
of cell death, initially identified by highly characteristic ous cell loss during the progression of glomerular injury
morphological changes, including condensation of nu- to scarring [32]. First, they observed marked increases
clear chromatin and the cytoplasm, and now known to in glomerular cell apoptosis in renal biopsy specimens
be the result of an ordered series of biochemical events from patients with IgA nephropathy. The greatest num-
within the dying cell [1, 2, 17]. Prominent among these ber, up to one apoptotic cell per cross section, was found
is activation of a family of cysteine proteases called cas- in lesions described as “predominantly sclerosing.” This
pases, which act on multiple intracellular targets to lead represents a very significant rate of cell loss, up to 24
to characteristic changes such as endonuclease-mediated per cross section per day, as the usual time taken for
internucleosomal chromatin cleavage (“DNA” ladder- cells to undergo apoptosis and subsequent phagocytic
ing) and plasma membrane alterations, including expo- degradation beyond histological recognition is around
sure of the anionic phospholipid phosphatidylserine (PS) only one hour [33–35]. Furthermore, in both IgA ne-
[18–23]. In turn, PS exposure and other membrane phropathy and a smaller series of biopsies from patients
changes rapidly lead to the recognition by phagocytes with lupus nephritis, there was a statistically significant
and swift, histologically inconspicuous removal and deg- correlation between the number of apoptotic cells per
radation of the intact dying cell, preventing injury of glomerular cross section and a semiquantitative “sclero-
surrounding tissues by the uncontrolled release of nox- sis” score; although mitotic figures were not counted,
ious cell contents [reviewed in 24, 25]. It is now widely there was no clear correlation between apoptosis and a
recognized that apoptosis is the normal means by which semiquantitative score of proliferation. The possibility
unwanted or surplus cells are deleted during tissue ho- that there might be a causal relationship between in-
meostasis. creased apoptosis and the net cell loss from glomeruli
Consequently, when apoptosis was first described in undergoing sclerosis was strengthened by additional ob-
1988 in glomerular disease by Harrison [26], it was ratio- servations on the rat remnant kidney model [32], in which
nal to focus attention on the possible role of apoptosis five-sixths nephrectomy leads rapidly to glomerular and
in deleting unwanted cells from the glomerulus [27], par- interstitial fibrosis accompanied by progressively im-
ticularly in view of data implicating apoptosis in clear- paired renal function. There was clear evidence of sig-
ance of infiltrating leukocytes [28, 29]. Indeed, following nificantly increased apoptosis in both glomeruli and
demonstration in vitro that the program of apoptosis tubules compared with sham-operated animals. Further-
was available to the mesangial cell [3], two independent more, a study by Shimizu et al of an animal model of
studies implicated mesangial cell apoptosis as the major severe crescentic glomerulonephritis also emphasized
mechanism mediating beneficial deletion of excess mes- the persistence of increased apoptosis beyond the stage
angial cells during spontaneous resolution of mesangial of hypercellularity in glomeruli destined to become hy-
hypercellularity in the Thy 1.1 model in the rat [3, 30]. pocellular scars [36].
In the second study, the characteristic wave of mesangial Consequently, we have proposed that, much as may
cell mitosis in this model was followed by a wave of be the case for glomerular cell proliferation, apoptosis
in glomerular cells can be regarded as a “double-edgedapoptosis [30], but presumably because of minor experi-
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Fig. 1. The “double-edged sword” of apop-
tosis. Depending upon the response of the
cell after glomerular injury, there may be a
beneficial deletion of excess resident glomeru-
lar cells or a more dramatic increase in cell
death that contributes to the progression of
renal disease and eventually to end-stage hy-
pocellular kidney.
sword,” sometimes promoting resolution of glomerular REGULATION OF GLOMERULAR
CELL APOPTOSISinjury by beneficial deletion of excess resident glomeru-
lar cells but, at other times, contributing to the progres- Because techniques for renal cell culture are well es-
sion to the end-stage hypocellular kidney (Fig. 1) [4]. tablished and assays for apoptosis are relatively straight-
Therefore, although therapeutic regulation of glomeru- forward in vitro, there has been a growing interest in
lar cell apoptosis might appear dauntingly complex, un- defining factors that might trigger apoptosis in glomeru-
derstanding the controls on apoptosis in such cells is lar cells. A number of stimuli have been identified (Table
likely to contribute greatly to the elucidation of the 1), some emphasizing that apoptosis can be an “altruis-
tic” response in cells receiving injury insufficient to causepathogenesis of glomerular disease.
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Table 1. Stimuli reported to trigger mesangial cell apoptosis dently regulated by proinflammatory cytokines such as
in culture
g-interferon [63, 64].
Selected The potential importance of Fas ligation in unsched-
Stimulus references
uled glomerular cell apoptosis has been further empha-
Non-specific sized in studies of mesangial cell “survival factors,”Serum starvation [3, 37]
agents that promote cell survival by inhibiting apoptosis.Detachment [38]
Shear stress [39] Raff has proposed the important hypothesis that all cells
Hydrostatic pressure [39] in the adult body will inevitably undergo apoptosis unlessDNA damage [39]
Reactive oxygen species [40–42] they receive a sufficient supply of survival signals [65].
Ionizing radiation [43] By contrast with the highly conserved death pathway in
Cytotoxic drugs [3, 43]
the metazoan cell, there is growing evidence that survivalSpecific
Anti-Thy 1.1 antibodies [44, 45] factors are integrated to provide exquisitely lineage-spe-
Anti-Fas antibodies [46] cific signals, which are spatially localized to ensure thatTNFa [47, 48]
cells that wander from their correct home do not prosperIL-1a [47]
IL-1b [43] but undergo apoptosis instead [66]. We showed that insu-
C1q [45]
lin-like growth factor-1 (IGF-1) and IGF-II were ableAnti-dsDNA antibodies [49]
LDL [50] to inhibit apoptosis induced in cultured mesangial cells
Lovastatin [51] by serum starvation, etoposide-mediated DNA damage,
Nitric oxide [52–54]
or cycloheximide-mediated inhibition of protein synthe-Superoxide [53]
Cyclic AMP [55] sis [38]. However, the specificity of cytokine survival
Abbreviations are: TNF, tumor necrosis factor; IL-1, interleukin-1; LDL, low signals was emphasized by the failure of either platelet-
density lipoprotein. derived growth factor, a potent mesangial cell mitogen,
or epithelial growth factor, a potential survival signal for
renal tubular cells, to provide survival signals to mesan-
gial cells. Furthermore, there was evidence of IGF-1–primary necrosis [2], the stricken cell adopting a poten-
mediated “paracrine” survival signaling, which mighttially noninflammatory mode of death. However, as in
sustain expanded populations of mesangial cells, as me-studies of glomerular cell survival (discussed later in this
dium conditioned by healthy mesangial cells was alsoarticle), the in vivo relevance of many of the reported
stimuli remains speculative. able to inhibit apoptosis in “stressed” cells, a prop-
Nevertheless, there are two well-established examples erty specifically diminished by neutralizing antibody to
of proapoptotic stimuli that not only induce glomerular IGF-1. Nevertheless, suitably sensitized mesangial cells
mesangial cell death in vitro but also trigger apoptosis were not rescued by IGF-1 from Fas-mediated apoptosis,
in this cell type in vivo. The relevance to disease of demonstrating that survival signals can be overridden by
Thy 1.1 ligation as a mechanism for rat mesangial cell Fas ligation and reinforcing the potential role of this
apoptosis in vitro [44, 56] and in vivo [9, 56] is question- cell death signaling system in “undesirable” apoptosis in
able, but Ortiz et al have studied the role of the Fas glomerular disease [38, 67].
death receptor [46], which is very likely to be involved In nonrenal cell types, it appears that survival signals
in human disease. Fas is a member of the tumor necrosis can also be supplied by ECM via heterodimeric cell sur-
factor (TNF) receptor family that appears specialized for face receptors of the integrin superfamily [66, 68, 69].
engaging apoptosis by being “hot-wired” to the caspase Comparable data are now available for glomerular mes-
cascade through adaptor molecules, including FADD
angial cells (abstract; Mooney et al, J Am Soc Nephrol
and caspase-8 (FLICE), once the receptor has been tri-
7:1760, 1996) [39, 70, 71]. Our own data raise the interest-merized by its TNF-like ligand (FasL) [57–59]. Although
ing possibility that changes in glomerular ECM typicalthe administration of Fas cross-linking antibody to mice
of progressive disease might increase the susceptibilityultimately incites fatal liver injury consequent on apopto-
of glomerular cells to “undesirable” apoptosis (abstract;sis in Fas-expressing hepatocytes, clear evidence was ob-
ibid) [70]. Thus, although normal constituents of mesan-tained that Fas ligation also induced glomerular cell
gial ECM, such as type IV collagen and laminin suppliedapoptosis [46, 60]. This important work established a
b1 integrin-mediated survival signals to serum-starvedcandidate mechanism for (unscheduled) glomerular cell
and etoposide-treated mesangial cells, it was notable thatapoptosis because FasL can be expressed by leukocyte
neither type I collagen nor plasma fibronectin signaledtypes known to infiltrate the glomerulus, such as mono-
survival. These abnormal mesangial ECM constituents,cyte/macrophages [61] and CD8-positive cytotoxic T
which accumulate in progressive disease, may thereforecells [62]. However, in vitro studies emphasize that mes-
angial cell susceptibility to ligation of Fas can be indepen- disrupt survival signaling from matrix.
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THE MACROPHAGE: MASTER OF THE sions as to the significance of apoptosis in control of
glomerular cell number and outcome of glomerular in-DOUBLE-EDGED SWORD?
jury can be drawn. There are no data from experimentsAccumulating data indicate that there are likely to
analogous to those that elegantly demonstrate a key rolebe many potentially counterbalancing influences on
for mediators such as platelet-derived growth factorwhether glomerular cells survive, differentiate, divide,
(PDGF) in glomerular cell proliferation, either by spe-or die. These factors will be partially controlled by the
cific neutralization on the one hand [78] or by PDGFconstituent cells of the glomerulus itself—an example
gene transfer on the other [79]. Nevertheless, the capac-being mesangial cell production of IGF-I, which we have
ity of excessive apoptosis to disturb glomerular structuredemonstrated to be a mesangial cell survival factor. In-
and function in vivo has been directly demonstrated bydeed, it is possible to speculate that changes in glomeru-
the administration of anti-Fas antibody, and we can looklar cell synthesis of ECM constituents, metallopro-
forward to much work in this area. Certainly there isteinases, and their inhibitors might bring about an
much more to learn about the regulation of apoptosisirreversible increase in susceptibility of glomerular cells
in all three glomerular cell types [80, 81], and a long-to apoptosis.
term goal must be to analyze the significance of changesNevertheless, it is tempting to seek a cell type that
in glomerular cell number “set point” at various stagesmight play the role of master swordsman, promoting
of glomerular injury, repair, or progression to scarring.restitution and resolution where these are possible, but
This will require an integration of knowledge on controldeleting irreversibly damaged glomeruli by eliminating
of glomerular cell division, survival, or death. It seemsglomerular cells and allowing an accumulation of ECM.
certain, just like being subject to death or taxes, thatA few strands of evidence hint that the inflammatory
our current concepts will seem naive and simplistic inmacrophage could serve as a master cell in glomerular
retrospect.injury. First, the seminal work of Leibovich and Ross
established a requirement for macrophages in wound
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